Language in India, ISSN 1930-2940, 03/2015, Volume 15, Issue 3, pp. 85 - 95
The current study is conducted for presenting a critical discourse analysis of the mob's language that assembled to record protest against gas and electricity...
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9663, pp. 567 - 574
Summary Background The role and dose of anticoagulants in thromboprophylaxis for patients with cancer receiving chemotherapy through central venous catheters...
Internal Medicine | PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | CENTRAL VEIN CATHETER | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | DOUBLE-BLIND | PREVENTION | COMPLICATIONS | THROMBOEMBOLISM | Meta-Analysis as Topic | Humans | Middle Aged | Neoplasms - mortality | Warfarin - adverse effects | Anticoagulants - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Anticoagulants - adverse effects | Venous Thrombosis - etiology | Neoplasms - drug therapy | Warfarin - therapeutic use | International Normalized Ratio | Female | Venous Thrombosis - prevention & control | Aged | Hemorrhage - chemically induced | Catheterization, Central Venous - adverse effects | Prevention | Cancer patients | Care and treatment | Warfarin | Antibiotics | Central venous catheters | Dosage and administration | Health aspects | Thrombosis | Blood clot | Risk factors | Clinical trials | Medical research | Drug therapy | Catheters | Cancer | Index Medicus | Abridged Index Medicus
Internal Medicine | PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | CENTRAL VEIN CATHETER | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | DOUBLE-BLIND | PREVENTION | COMPLICATIONS | THROMBOEMBOLISM | Meta-Analysis as Topic | Humans | Middle Aged | Neoplasms - mortality | Warfarin - adverse effects | Anticoagulants - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Anticoagulants - adverse effects | Venous Thrombosis - etiology | Neoplasms - drug therapy | Warfarin - therapeutic use | International Normalized Ratio | Female | Venous Thrombosis - prevention & control | Aged | Hemorrhage - chemically induced | Catheterization, Central Venous - adverse effects | Prevention | Cancer patients | Care and treatment | Warfarin | Antibiotics | Central venous catheters | Dosage and administration | Health aspects | Thrombosis | Blood clot | Risk factors | Clinical trials | Medical research | Drug therapy | Catheters | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2005, Volume 23, Issue 36, pp. 9219 - 9226
Purpose: Early mortality in multiple myeloma (MM) is usually attributed to combined effects of active disease and comorbid factors. We have studied early...
STAGING SYSTEM | SURVIVAL | PROGNOSTIC-FACTORS | ONCOLOGY | SEVERE RENAL-FAILURE | RANDOMIZED-TRIAL | GAMMA-GLOBULIN | RISK | INFECTION | STEM-CELL TRANSPLANT | CHEMOTHERAPY | Prognosis | Age Factors | Comorbidity | Multiple Myeloma - mortality | Humans | Middle Aged | Logistic Models | Male | Multiple Myeloma - pathology | Sensitivity and Specificity | Female | Renal Insufficiency - complications | Aged | Retrospective Studies | Neoplasm Staging | Infection - complications
STAGING SYSTEM | SURVIVAL | PROGNOSTIC-FACTORS | ONCOLOGY | SEVERE RENAL-FAILURE | RANDOMIZED-TRIAL | GAMMA-GLOBULIN | RISK | INFECTION | STEM-CELL TRANSPLANT | CHEMOTHERAPY | Prognosis | Age Factors | Comorbidity | Multiple Myeloma - mortality | Humans | Middle Aged | Logistic Models | Male | Multiple Myeloma - pathology | Sensitivity and Specificity | Female | Renal Insufficiency - complications | Aged | Retrospective Studies | Neoplasm Staging | Infection - complications
Journal Article
Glia, ISSN 0894-1491, 10/2016, Volume 64, Issue 10, pp. 1677 - 1697
Sodium dynamics are essential for regulating functional processes in glial cells. Indeed, glial Na+ signaling influences and regulates important glial...
Na+‐HCO3‐ cotransporter | Na+/Ca2+ exchanger | Na+/H+ exchanger | Na+‐K+‐Cl‐ cotransporter | Na+/K+ ATPase | oligodendrocytes | astrocytes | microglia | HCO | ATPase | exchanger | Cl | cotransporter | Ca | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | CATION-CHLORIDE COTRANSPORTERS | CULTURED RAT ASTROCYTES | FOCAL CEREBRAL-ISCHEMIA | EXCHANGER ISOFORM 1 | INTRACELLULAR PH REGULATION | AMYOTROPHIC-LATERAL-SCLEROSIS | NEUROSCIENCES | WHITE-MATTER INJURY | K+-CL-COTRANSPORTER | CENTRAL-NERVOUS-SYSTEM | Na+-HCO3- cotransporter | Na+-K+-Cl- cotransporter | Animals | Humans | Neuroglia - physiology | Membrane Transport Proteins - metabolism | Signal Transduction - physiology | Sodium - metabolism | Ion Transport - physiology | Nervous System Diseases - pathology | Nervous system diseases | Adenosine triphosphatase | Homeostasis | Alzheimers disease | Rodents | Na+-HCO3− cotransporter | K+ ATPase | H+ exchanger | Ca2+ exchanger | Na+ | Na+-K+-Cl− cotransporter
Na+‐HCO3‐ cotransporter | Na+/Ca2+ exchanger | Na+/H+ exchanger | Na+‐K+‐Cl‐ cotransporter | Na+/K+ ATPase | oligodendrocytes | astrocytes | microglia | HCO | ATPase | exchanger | Cl | cotransporter | Ca | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | CATION-CHLORIDE COTRANSPORTERS | CULTURED RAT ASTROCYTES | FOCAL CEREBRAL-ISCHEMIA | EXCHANGER ISOFORM 1 | INTRACELLULAR PH REGULATION | AMYOTROPHIC-LATERAL-SCLEROSIS | NEUROSCIENCES | WHITE-MATTER INJURY | K+-CL-COTRANSPORTER | CENTRAL-NERVOUS-SYSTEM | Na+-HCO3- cotransporter | Na+-K+-Cl- cotransporter | Animals | Humans | Neuroglia - physiology | Membrane Transport Proteins - metabolism | Signal Transduction - physiology | Sodium - metabolism | Ion Transport - physiology | Nervous System Diseases - pathology | Nervous system diseases | Adenosine triphosphatase | Homeostasis | Alzheimers disease | Rodents | Na+-HCO3− cotransporter | K+ ATPase | H+ exchanger | Ca2+ exchanger | Na+ | Na+-K+-Cl− cotransporter
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 02/2012, Volume 120, Issue 4, pp. 622 - 630
J. Neurochem. (2012) 120, 622–630. Docosahexaenoic acid (DHA) has neuroprotective effects in several neurodegenerative disease conditions. However, the...
ER Ca2 | ER stress | ryanodine receptor | IP3 receptor | polyunsaturated fatty acid | CELLS | RAT | BIOCHEMISTRY & MOLECULAR BIOLOGY | FATTY-ACIDS | ARACHIDONIC-ACID | RELEASE | NEUROSCIENCES | UNFOLDED PROTEIN RESPONSE | K+-CL-COTRANSPORTER | DOCOSAHEXAENOIC ACID | ENDOPLASMIC-RETICULUM | BRAIN | Astrocytes - drug effects | Cell Hypoxia - drug effects | Cell Hypoxia - physiology | Endoplasmic Reticulum Stress - drug effects | Calcium - metabolism | Calcium Signaling - physiology | Astrocytes - pathology | Cells, Cultured | Ischemia - metabolism | Endoplasmic Reticulum - secretion | Calcium - antagonists & inhibitors | Docosahexaenoic Acids - pharmacology | Endoplasmic Reticulum - pathology | Animals | Neuroprotective Agents - pharmacology | Calcium Signaling - drug effects | Endoplasmic Reticulum - drug effects | Oxidation-Reduction - drug effects | Mice | Ischemia - pathology | Astrocytes - secretion | Endoplasmic Reticulum Stress - physiology | Neurochemistry | Oxidative stress | Signal transduction | Brain | Ischemia
ER Ca2 | ER stress | ryanodine receptor | IP3 receptor | polyunsaturated fatty acid | CELLS | RAT | BIOCHEMISTRY & MOLECULAR BIOLOGY | FATTY-ACIDS | ARACHIDONIC-ACID | RELEASE | NEUROSCIENCES | UNFOLDED PROTEIN RESPONSE | K+-CL-COTRANSPORTER | DOCOSAHEXAENOIC ACID | ENDOPLASMIC-RETICULUM | BRAIN | Astrocytes - drug effects | Cell Hypoxia - drug effects | Cell Hypoxia - physiology | Endoplasmic Reticulum Stress - drug effects | Calcium - metabolism | Calcium Signaling - physiology | Astrocytes - pathology | Cells, Cultured | Ischemia - metabolism | Endoplasmic Reticulum - secretion | Calcium - antagonists & inhibitors | Docosahexaenoic Acids - pharmacology | Endoplasmic Reticulum - pathology | Animals | Neuroprotective Agents - pharmacology | Calcium Signaling - drug effects | Endoplasmic Reticulum - drug effects | Oxidation-Reduction - drug effects | Mice | Ischemia - pathology | Astrocytes - secretion | Endoplasmic Reticulum Stress - physiology | Neurochemistry | Oxidative stress | Signal transduction | Brain | Ischemia
Journal Article
Neuro-Oncology, ISSN 1522-8517, 11/2019, Volume 21, Issue Supplement_6, pp. vi44 - vi44
Abstract Low-grade gliomas (LGGs) present a high incidence of epilepsy, infiltrative growth, resistance to therapy, and high risk of transforming into...
Journal Article
Science Signaling, ISSN 1945-0877, 08/2016, Volume 9, Issue 439, pp. ra77 - ra77
Using exome sequencing, we identified a de novo mutation (c.2971A>G; T991A) in SLC12A6, the gene encoding the K+-Cl(-)cotransporter KCC3, in a patient with an...
HEREDITARY MOTOR | CATION-CHLORIDE COTRANSPORTERS | K+-CL-COTRANSPORTER | BIOCHEMISTRY & MOLECULAR BIOLOGY | CORPUS-CALLOSUM | DISEASE | ANDERMANN-SYNDROME | CONDITIONAL MOUSE MODEL | MICE | CELL-VOLUME HOMEOSTASIS | MISSENSE MUTATIONS | CELL BIOLOGY | WNK Lysine-Deficient Protein Kinase 1 - metabolism | Humans | Peripheral Nervous System Diseases - enzymology | Male | Motor Neurons - enzymology | Mutation, Missense | Motor Neurons - pathology | Symporters - metabolism | Phosphorylation - genetics | Animals | Mice, Mutant Strains | Symporters - genetics | HEK293 Cells | Female | Mice | Peripheral Nervous System Diseases - pathology | Peripheral Nervous System Diseases - genetics | WNK Lysine-Deficient Protein Kinase 1 - genetics
HEREDITARY MOTOR | CATION-CHLORIDE COTRANSPORTERS | K+-CL-COTRANSPORTER | BIOCHEMISTRY & MOLECULAR BIOLOGY | CORPUS-CALLOSUM | DISEASE | ANDERMANN-SYNDROME | CONDITIONAL MOUSE MODEL | MICE | CELL-VOLUME HOMEOSTASIS | MISSENSE MUTATIONS | CELL BIOLOGY | WNK Lysine-Deficient Protein Kinase 1 - metabolism | Humans | Peripheral Nervous System Diseases - enzymology | Male | Motor Neurons - enzymology | Mutation, Missense | Motor Neurons - pathology | Symporters - metabolism | Phosphorylation - genetics | Animals | Mice, Mutant Strains | Symporters - genetics | HEK293 Cells | Female | Mice | Peripheral Nervous System Diseases - pathology | Peripheral Nervous System Diseases - genetics | WNK Lysine-Deficient Protein Kinase 1 - genetics
Journal Article
Glia, ISSN 0894-1491, 01/2018, Volume 66, Issue 1, pp. 126 - 144
Stimulation of Na+/H+ exchanger isoform 1 (NHE1) in astrocytes causes ionic dysregulation under ischemic conditions. In this study, we created a Nhe1flox/flox...
MMP | blood–brain barrier | gliosis | cerebral edema | astrocyte end‐feet | neurovascular unit | astrocyte end-feet | blood-brain barrier | NEUROSCIENCES | Glial Fibrillary Acidic Protein - genetics | Cerebrovascular Circulation - physiology | Male | Cerebrovascular Circulation - genetics | Glial Fibrillary Acidic Protein - metabolism | Blood-Brain Barrier - ultrastructure | Gliosis - pathology | Matrix Metalloproteinase 9 - metabolism | Reperfusion | Infarction, Middle Cerebral Artery - complications | Gliosis - etiology | Disease Models, Animal | Microscopy, Electron, Transmission | Gliosis - genetics | Brain Infarction - diagnosis | Gene Expression Regulation - genetics | Gliosis - metabolism | Mice, Inbred C57BL | Sodium-Hydrogen Exchanger 1 - genetics | Mice, Transgenic | Infarction, Middle Cerebral Artery - pathology | Astrocytes - ultrastructure | Blood-Brain Barrier - pathology | Brain Infarction - etiology | Motor Activity - genetics | Sodium-Hydrogen Exchanger 1 - deficiency | Animals | Neurologic Examination | Mice | Brain Infarction - genetics | Astrocytes - metabolism | Stroke (Disease) | Brain damage | Ischemia | Cytochemistry | Proteases | Analysis | Occlusion | Matrix metalloproteinases | Hydrogen | Recombinase | Gene deletion | Corn oil | Clonal deletion | Blood-brain barrier | Nhe1 gene | Cerebral blood flow | Rodents | Deletion | Cerebral infarction | Edema | Stroke | Tight junctions | Astrocytes | Na+/H+-exchanging ATPase | Inflammation | Tamoxifen | Ablation | Endothelial cells | Flox | Gelatinase B | Blood flow | Neurological diseases | Injury prevention | Gliosis | Infarction | Brain injury | Hypertrophy
MMP | blood–brain barrier | gliosis | cerebral edema | astrocyte end‐feet | neurovascular unit | astrocyte end-feet | blood-brain barrier | NEUROSCIENCES | Glial Fibrillary Acidic Protein - genetics | Cerebrovascular Circulation - physiology | Male | Cerebrovascular Circulation - genetics | Glial Fibrillary Acidic Protein - metabolism | Blood-Brain Barrier - ultrastructure | Gliosis - pathology | Matrix Metalloproteinase 9 - metabolism | Reperfusion | Infarction, Middle Cerebral Artery - complications | Gliosis - etiology | Disease Models, Animal | Microscopy, Electron, Transmission | Gliosis - genetics | Brain Infarction - diagnosis | Gene Expression Regulation - genetics | Gliosis - metabolism | Mice, Inbred C57BL | Sodium-Hydrogen Exchanger 1 - genetics | Mice, Transgenic | Infarction, Middle Cerebral Artery - pathology | Astrocytes - ultrastructure | Blood-Brain Barrier - pathology | Brain Infarction - etiology | Motor Activity - genetics | Sodium-Hydrogen Exchanger 1 - deficiency | Animals | Neurologic Examination | Mice | Brain Infarction - genetics | Astrocytes - metabolism | Stroke (Disease) | Brain damage | Ischemia | Cytochemistry | Proteases | Analysis | Occlusion | Matrix metalloproteinases | Hydrogen | Recombinase | Gene deletion | Corn oil | Clonal deletion | Blood-brain barrier | Nhe1 gene | Cerebral blood flow | Rodents | Deletion | Cerebral infarction | Edema | Stroke | Tight junctions | Astrocytes | Na+/H+-exchanging ATPase | Inflammation | Tamoxifen | Ablation | Endothelial cells | Flox | Gelatinase B | Blood flow | Neurological diseases | Injury prevention | Gliosis | Infarction | Brain injury | Hypertrophy
Journal Article
Glia, ISSN 0894-1491, 11/2018, Volume 66, Issue 11, pp. 2279 - 2298
Na+/H+ exchanger (NHE1) activation is required for multiple microglial functions. We investigated effects of selective deletion of microglial Nhe1 in...
phagocytosis | macrophages | inflammation | microglia | white matter tissue repair | SURVIVAL | BRAIN-INJURY | FOCAL CEREBRAL-ISCHEMIA | RECEPTOR | CNS | NEUROSCIENCES | NEURONAL DEATH | GROWTH | MICE | EXPRESSION | Microglia - metabolism | Somatosensory Disorders - etiology | Brain - diagnostic imaging | Recovery of Function - drug effects | Male | CX3C Chemokine Receptor 1 - metabolism | CX3C Chemokine Receptor 1 - genetics | Infarction, Middle Cerebral Artery - complications | Recovery of Function - physiology | Female | Demyelinating Diseases - etiology | Infarction, Middle Cerebral Artery - drug therapy | Microfilament Proteins - metabolism | Infarction, Middle Cerebral Artery - diagnostic imaging | Demyelinating Diseases - drug therapy | Disease Models, Animal | Calcium-Binding Proteins - metabolism | Macrophages - pathology | Microglia - drug effects | Gene Expression Regulation - genetics | Mice, Inbred C57BL | Sodium-Hydrogen Exchanger 1 - genetics | Mice, Transgenic | Nerve Tissue Proteins - genetics | White Matter - pathology | Brain - drug effects | Gene Expression Regulation - drug effects | Nerve Tissue Proteins - metabolism | Macrophages - metabolism | White Matter - diagnostic imaging | Animals | Tamoxifen - pharmacology | Sodium-Hydrogen Exchanger 1 - metabolism | Mice | Stroke (Disease) | Neurons | Analysis | Brain damage | Bone morphogenetic proteins | Inflammation | Macrophages | Transforming growth factors | Brain | CD86 antigen | Hydrogen | CX3CR1 protein | Activation | Recovery | Proteins | Cell activation | Corn oil | Clonal deletion | Ischemia | Demyelination | Rodents | Animal tissues | Deletion | Lesions | Repair | Stroke | CD11b antigen | Cell survival | Therapeutic applications | Astrocytes | Na+/H+-exchanging ATPase | Glial fibrillary acidic protein | Tamoxifen | Substantia alba | Survival | Microglia | Myelination | Brain injury | Ca2+/calmodulin-dependent protein kinase II
phagocytosis | macrophages | inflammation | microglia | white matter tissue repair | SURVIVAL | BRAIN-INJURY | FOCAL CEREBRAL-ISCHEMIA | RECEPTOR | CNS | NEUROSCIENCES | NEURONAL DEATH | GROWTH | MICE | EXPRESSION | Microglia - metabolism | Somatosensory Disorders - etiology | Brain - diagnostic imaging | Recovery of Function - drug effects | Male | CX3C Chemokine Receptor 1 - metabolism | CX3C Chemokine Receptor 1 - genetics | Infarction, Middle Cerebral Artery - complications | Recovery of Function - physiology | Female | Demyelinating Diseases - etiology | Infarction, Middle Cerebral Artery - drug therapy | Microfilament Proteins - metabolism | Infarction, Middle Cerebral Artery - diagnostic imaging | Demyelinating Diseases - drug therapy | Disease Models, Animal | Calcium-Binding Proteins - metabolism | Macrophages - pathology | Microglia - drug effects | Gene Expression Regulation - genetics | Mice, Inbred C57BL | Sodium-Hydrogen Exchanger 1 - genetics | Mice, Transgenic | Nerve Tissue Proteins - genetics | White Matter - pathology | Brain - drug effects | Gene Expression Regulation - drug effects | Nerve Tissue Proteins - metabolism | Macrophages - metabolism | White Matter - diagnostic imaging | Animals | Tamoxifen - pharmacology | Sodium-Hydrogen Exchanger 1 - metabolism | Mice | Stroke (Disease) | Neurons | Analysis | Brain damage | Bone morphogenetic proteins | Inflammation | Macrophages | Transforming growth factors | Brain | CD86 antigen | Hydrogen | CX3CR1 protein | Activation | Recovery | Proteins | Cell activation | Corn oil | Clonal deletion | Ischemia | Demyelination | Rodents | Animal tissues | Deletion | Lesions | Repair | Stroke | CD11b antigen | Cell survival | Therapeutic applications | Astrocytes | Na+/H+-exchanging ATPase | Glial fibrillary acidic protein | Tamoxifen | Substantia alba | Survival | Microglia | Myelination | Brain injury | Ca2+/calmodulin-dependent protein kinase II
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2005, Volume 23, Issue 36, pp. 9387 - 9393
Purpose The toxicity of allogeneic stem-cell transplantation can be substantially reduced using a reduced-intensity conditioning (RIC) regimen. This has...
AML | SOUTHWEST-ONCOLOGY-GROUP | ONCOLOGY | IMMUNOTHERAPY | BONE-MARROW-TRANSPLANTATION | IN-VIVO | MALIGNANCIES | 1ST COMPLETE REMISSION | VERSUS-HOST-DISEASE | FLUDARABINE | BUSULFAN | Recurrence | Acute Disease | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Vidarabine - analogs & derivatives | Transplantation, Homologous | Graft vs Host Disease | Leukemia, Myeloid - pathology | Stem Cell Transplantation | Disease-Free Survival | Leukemia, Myeloid - drug therapy | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Adult | Female | Aged | Vidarabine - administration & dosage | Myelodysplastic Syndromes - pathology | Myelodysplastic Syndromes - drug therapy
AML | SOUTHWEST-ONCOLOGY-GROUP | ONCOLOGY | IMMUNOTHERAPY | BONE-MARROW-TRANSPLANTATION | IN-VIVO | MALIGNANCIES | 1ST COMPLETE REMISSION | VERSUS-HOST-DISEASE | FLUDARABINE | BUSULFAN | Recurrence | Acute Disease | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Vidarabine - analogs & derivatives | Transplantation, Homologous | Graft vs Host Disease | Leukemia, Myeloid - pathology | Stem Cell Transplantation | Disease-Free Survival | Leukemia, Myeloid - drug therapy | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Adult | Female | Aged | Vidarabine - administration & dosage | Myelodysplastic Syndromes - pathology | Myelodysplastic Syndromes - drug therapy
Journal Article
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, ISSN 1756-9966, 10/2018, Volume 37, Issue 1, pp. 255 - 16
BackgroundSodium/hydrogen exchanger 1 (NHE1), encoded by the SLC9A1 gene (SoLute Carrier family 9A1) in humans, is the main H+ efflux mechanism in maintaining...
MIGRATION | NHE1 | IDH MUTATION | TUMOR | macrophage | NHE1 inhibitor HOE642 | CELL-PROLIFERATION | Anti-PD1 therapy | IMMUNE | Angiogenesis | Immunosuppression | ONCOLOGY | Tumor-associated microglia | GASTRIC-CANCER | UP-REGULATION | EXPRESSION | PROGRESSION | Neoplasm Transplantation | Up-Regulation | Prognosis | Humans | Brain Neoplasms - pathology | Gene Expression Regulation, Neoplastic | Guanidines - pharmacology | Male | Gene Expression Profiling | Sulfones - pharmacology | Brain Neoplasms - metabolism | Glioma - metabolism | Glioma - genetics | Neoplasm Grading | Glioma - pathology | Female | Guanidines - administration & dosage | Cell Survival - drug effects | Mice, Inbred C57BL | Brain Neoplasms - genetics | Sodium-Hydrogen Exchanger 1 - genetics | Brain Neoplasms - drug therapy | Animals | Sequence Analysis, RNA | Survival Analysis | Cell Line, Tumor | Sodium-Hydrogen Exchanger 1 - metabolism | Cell Proliferation - drug effects | Mice | Glioma - drug therapy | Sulfones - administration & dosage | Glycolysis | Research | Gliomas | Carcinogenesis | Cancer cells | Dehydrogenases | Brain cancer | Genomes | Cancer therapies | Datasets | Studies | Proteins | Survival analysis | Medical prognosis | Hypoxia | Tumorigenesis | Bioinformatics | Tumors | Tumor-associated microglia/macrophage
MIGRATION | NHE1 | IDH MUTATION | TUMOR | macrophage | NHE1 inhibitor HOE642 | CELL-PROLIFERATION | Anti-PD1 therapy | IMMUNE | Angiogenesis | Immunosuppression | ONCOLOGY | Tumor-associated microglia | GASTRIC-CANCER | UP-REGULATION | EXPRESSION | PROGRESSION | Neoplasm Transplantation | Up-Regulation | Prognosis | Humans | Brain Neoplasms - pathology | Gene Expression Regulation, Neoplastic | Guanidines - pharmacology | Male | Gene Expression Profiling | Sulfones - pharmacology | Brain Neoplasms - metabolism | Glioma - metabolism | Glioma - genetics | Neoplasm Grading | Glioma - pathology | Female | Guanidines - administration & dosage | Cell Survival - drug effects | Mice, Inbred C57BL | Brain Neoplasms - genetics | Sodium-Hydrogen Exchanger 1 - genetics | Brain Neoplasms - drug therapy | Animals | Sequence Analysis, RNA | Survival Analysis | Cell Line, Tumor | Sodium-Hydrogen Exchanger 1 - metabolism | Cell Proliferation - drug effects | Mice | Glioma - drug therapy | Sulfones - administration & dosage | Glycolysis | Research | Gliomas | Carcinogenesis | Cancer cells | Dehydrogenases | Brain cancer | Genomes | Cancer therapies | Datasets | Studies | Proteins | Survival analysis | Medical prognosis | Hypoxia | Tumorigenesis | Bioinformatics | Tumors | Tumor-associated microglia/macrophage
Journal Article